Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.
Jonchere B, Williams J, Zindy F, Liu J, Robinson S, Farmer DM, Min J, Yang L, Stripay JL, Wang Y, Freeman BB, Yu J, Shelat AA, Rankovic Z, Roussel MF.
Jonchere B, et al. Among authors: zindy f.
Mol Cancer Ther. 2023 Jan 3;22(1):37-51. doi: 10.1158/1535-7163.MCT-21-0896.
Mol Cancer Ther. 2023.
PMID: 36318650
Free PMC article.